Hongrui Meng

Dr. Hongrui Meng

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2024 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
YMYongzhen Miao
Yongzhen Miao
HMHongrui Meng
Hongrui Meng
The intracellular deposition and intercellular transmission of α-synuclein (α-syn) are shared pathological characteristics among neurodegenerative disorders collectively known as α-synucleinopathies, including Parkinson's disease (PD). Although the precise triggers of α-synucleinopathies remain unclear, recent findings indicate that disruption of microglial homeostasis contributes to the pathogenesis of PD. Microglia play a crucial role in maintaining optimal neuronal function by ensuring a homeostatic environment, but this function is disrupted during the progression of α-syn pathology. The involvement of microglia in the accumulation, uptake, and clearance of aggregated proteins is critical for managing disease spread and progression caused by α-syn pathology. This review summarizes current knowledge on the interrelationships between microglia and α-synucleinopathies, focusing on the remarkable ability of microglia to recognize and internalize extracellular α-syn through diverse pathways. Microglia process α-syn intracellularly and intercellularly to facilitate the α-syn neuronal aggregation and cell-to-cell propagation. The conformational state of α-synuclein distinctly influences microglial inflammation, which can affect peripheral immune cells such as macrophages and lymphocytes and may regulate the pathogenesis of α-synucleinopathies. We also discuss ongoing research efforts to identify potential therapeutic approaches targeting both α-syn accumulation and inflammation in PD.

27 October 2025 in Molecular Neurodegeneration
Verified
Journal Article
Open access
PDF file
YMYongzhen Miao
Yongzhen Miao
TZTing Zhang
Ting Zhang
ZMZhuoya Ma
Zhuoya Ma
HDHuanhuan Du
Huanhuan Du
QGQipei Gu
Qipei Gu
HMHongrui Meng
Hongrui Meng
Background: The accumulation and propagation of α-synuclein (α-syn) are hallmark features of Parkinson’s disease (PD) and related neurodegenerative disorders. O-GlcNAcylation, an abundant post-translational modification throughout the brain, is regulated by the enzymatic activity of the cycling enzymes O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA) and has been implicated in altering α-syn toxicity. Nevertheless, the interplay between modulating O-GlcNAc cycling and α-syn aggregation and the propagation of amyloid pathology is not well elucidated. Methods: To this end, we delivered conformational strains of α-syn in the striatum of mice or neuronal and microglial co-cultured cells following pharmacologically or genetically inhibited OGT and OGA. The substantia nigra was injected with an adeno-associated viral vector coding for α-syn combined with α-syn preformed fibrils to examine α-syn-induced dopaminergic cytotoxicity. The α-syn pathology and spreading, protein O-GlcNAcylation, OGT and OGA levels, microglial inflammation, and behavioral impairments were evaluated. Furthermore, the O-GlcNAc modification and proteolysis status of α-syn under O-GlcNAc cycling modification were also assessed using a combination of approaches, including Click-iT™ O-GlcNAc enzyme labeling, sWGA pulldown, HPLC-MS/MS, and immunohistochemical analysis following proteasome and autophagy-lysosome inhibition. Results: We found that modulation of O-GlcNAc cycling, governed by the two enzymes OGT and OGA, significantly affected α-syn aggregation, propagation, dopaminergic neuronal degeneration, and microglial inflammation. Pathological α-syn transmission to adjacent cells and anatomically connected brain regions was found to suppress recipient cellular O-GlcNAc levels, concomitant with reduced OGT expression. Pharmacological inhibition or genetic knockdown of OGT exacerbated α-syn aggregation, enhanced its intercellular transmission, and intensified NOD-, LRR-, and pyrin domain-containing 3 (NLRP3)-mediated microglial inflammation. Conversely, increasing O-GlcNAcylation via OGA inhibition ameliorated these pathological processes. Furthermore, we demonstrate that enzymatic O-GlcNAcylation significantly regulates the aggregation of fibril-induced initial dimer formation and facilitates the clearance of α-syn aggregates through autophagosome-lysosome flux. Conclusions: These findings highlight the critical regulatory role of O-GlcNAc modification in α-syn pathology and conformational strain formation, and provide mechanical evidence that enhancing O-GlcNAc modifications alleviates pathological α-syn proteolysis by restoring autophagosome-lysosome flux.

30 July 2024 in PNAS Nexus
Verified
Journal Article
Open access
PDF file
AIAya Ikeda
Aya Ikeda
HMHongrui Meng
Hongrui Meng
DTDaisuke Taniguchi
Daisuke Taniguchi
MMMuneyo Mio
Muneyo Mio
MFManabu Funayama
Manabu Funayama
NHNobutaka Hattori
Nobutaka Hattori
CHCHD2 and CHCHD10, linked to Parkinson's disease and amyotrophic lateral sclerosis-frontotemporal dementia (ALS), respectively, are mitochondrial intermembrane proteins that form a heterodimer. This study aimed to investigate the impact of the CHCHD2 P14L variant, implicated in ALS, on mitochondrial function and its subsequent effects on cellular homeostasis. The missense variant of CHCHD2, P14L, found in a cohort of patients with ALS, mislocalized CHCHD2 to the cytoplasm, leaving CHCHD10 in the mitochondria. Drosophila lacking the CHCHD2 ortholog exhibited mitochondrial degeneration. In contrast, human CHCHD2 P14L, but not wild-type human CHCHD2, failed to suppress this degeneration, suggesting that P14L is a pathogenic variant. The mitochondrial Ca2+ buffering capacity was reduced in Drosophila neurons expressing human CHCHD2 P14L. The altered Ca2+-buffering phenotype was also observed in cultured human neuroblastoma SH-SY5Y cells expressing CHCHD2 P14L. In these cells, transient elevation of cytoplasmic Ca2+ facilitated the activation of calpain and caspase-3, accompanied by the processing and insolubilization of TDP-43. These observations suggest that CHCHD2 P14L causes abnormal Ca2+ dynamics and TDP-43 aggregation, reflecting the pathophysiology of ALS.

22 May 2024 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
YSYue Sun
Yue Sun
MJMengni Jiang
Mengni Jiang
XIANG LONGXIANG LONG
XIANG LONG
YMYongzhen Miao
Yongzhen Miao
HDHuanhuan Du
Huanhuan Du
HMHongrui Meng
Hongrui Meng

24 February 2023 in Journal of Visualized Experiments
Verified
Journal Article
Closed access
XIANG LONGXIANG LONG
XIANG LONG
HDHuanhuan Du
Huanhuan Du
MJMengni Jiang
Mengni Jiang
HMHongrui Meng
Hongrui Meng
A Simple Technique To Assay Locomotor Activity In Drosophila. JoVE publishes peer-reviewed scientific video protocols to accelerate biological, medical, chemical and physical research. Watch our scientific video articles. JoVE is the world-leading producer and provider of science videos with the mission to improve scientific research, scientific journals, and education. Millions of scientists, educators and students at thousands of universities, colleges, hospitals and biopharmaceutical companies worldwide use JoVE for their research, teaching and learning.

27 August 2026
Verified
Book Chapter
Open access
PDF file
HMHongrui Meng
Hongrui Meng
YMYongzhen Miao
Yongzhen Miao
ZMZhuoya Ma
Zhuoya Ma
CLChun-Feng Liu
Chun-Feng Liu
The accumulation of amyloidogenic α-synuclein (α-syn) is the prominent marker of Lewy bodies, typically deposited in neurons in Parkinson’s disease (PD) and several other neurodegenerative disorders. Various posttranslational modifications (PTMs), such as O-GlcNAcylation, occur in α-syn. Modification by O-GlcNAcylation effectively hinders α-syn aggregation and attenuates its cellular toxicity in vitro and in vivo. Robust methods are crucial for investigating O-GlcNAc modification of α-syn and understanding its pivotal roles in intricate cellular processes and diseases. Here, we describe biochemical approaches for evaluating the effect of O-GlcNAc modification on the neuronal toxicity of α-syn aggregates and detecting this modification through an enzymatic labeling method. Employing an enzymatic labeling approach to investigate α-syn O-GlcNAcylation also involves attaching defined molecular weights of polyethylene glycol polymers to O-GlcNAcylated proteins. Mass tag installation causes the O-GlcNAcylated proteins to shift upward when separated by SDS-PAGE electrophoresis. The O-GlcNAcylated α-syn protein, with a predictable molecular weight, can be determined using immunoblotting with a specific antibody. This approach enables the identification and distinction of the O-GlcNAcylated and non-O-GlcNAcylated forms of α-syn proteins, thereby allowing the quantification of the conformational fibril α-syn proteins modified by O-GlcNAcylation. These methods may represent a useful strategy for analyzing the posttranslational O-GlcNAc modifications of α-syn protein in various samples.